Imperial Innovations Group


Imperial Innovations Group plc acts as a holding company. It acts as a technology transfer business taking the inventions from Imperial College and commercializing them either through licensing or by forming a technology company. Its principal activities are technology commercialization and investments.

Imperial Innovations partner MET sold to Evonik Industries for 4.5m

Tuesday, March 02, 2010
company news image

Imperial Innovations Group (AIM: IVO) said its partner company Membrane Extraction Technology (MET), in which it holds a 20 percent stake, was sold to to Evonik Industries AG, a privately-owned German chemical manufacturer, for £4.5m in cash. Imperial Innovations received a cash payment of 903,976, resulting in a net payment of £653,409 after deducting the Imperial College's share of the proceeds.

The synergies between MET and Evonik make a compelling case for this excellent deal, MET CEO Professor Andrew Livingston said.

MET was founded in 1995 by Livingston in association with Imperial Innovation. The business specialises in chemical separation, and its international operation supplies the pharmaceutical and fine chemicals industries. Imperial Innovations' 20% equity stake resulted from its founding stake when it established the company in 1995 and a 50,000 investment in 2008. Oxford Technology Venture Capital Trust and Citigroup Capital Ventures also had an equity stake in the business.

Proactiveinvestors recommends

In its last financial year ended 31 July 2009, MET reported a profit of £11,102.

"MET is another good example of a trade sale of a business that has been built with a relatively modest amount of investment and highlights the success of our investment strategy, involving regular exits by our maturing companies, Imperial Innovation CEO Susan Searle commented.

In addition to the net proceeds, the company will also return its carrying value, in relation to MET, for reinvestment purposes. As at 31 July 2009, METs carrying value was £155,000.


Register here to be notified of future Imperial Innovations Group articles.

Investors interested in Imperial Innovations Group recently viewed

Additional Information

Market:AIM
Sector:General Financial
EPIC:IVO
Latest Price: 472.50p  (0.00%)
52-week High:537.50p
52-week Low:285.00p
Market Cap:282.51M

1 year chart

digital-look imported chart image

1 day chart

digital-look imported chart image

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.